Voglow 0.3 GM3 Tablet SR
Marketer
Primus Remedies Pvt Ltd
Salt Composition
Glimepiride (3mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Voglow 0.3 GM3 Tablet SR
Diabetace SR 0.3GM3 tablets are classified as antidiabetic medications. This combined-therapy formulation manages type 2 diabetes in adults by regulating blood glucose. Diabetace SR 0.3GM3 should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication is a component of a comprehensive diabetes management plan incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential preventative measures. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, will be recommended by your doctor.
Uses of Voglow 0.3 GM3 Tablet SR
Managing type 2 diabetes
Major Benefits of Voglow 0.3 GM3 Tablet SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglow 0.3 GM3 Tablet SR whole; do not fracture, chew, or crush it. Administer on an empty stomach.
Common Side effects of Voglow 0.3 GM3 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Voglow 0.3 GM3 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglow 0.3 GM3 Tablet SR whole; do not chew, crush, or divide the tablet. Administer on an empty stomach.
How Voglow 0.3 GM3 Tablet SR works:
Voglow 0.3 GM3 Extended-Release Tablets contain a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglow 0.3 GM3 Tablet SR and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Voglow 0.3 GM3 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Voglow 0.3 GM3 Tablet may pose risks to breastfeeding infants. Available data in humans indicates potential drug transfer via breast milk, potentially causing harm to the nursing child.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.
KidneyUNSAFE
The use of Voglow 0.3 GM3 Tablet SR is likely inadvisable for individuals with kidney impairment and should be forgone. Medical advice is recommended. Furthermore, its administration is discouraged in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Voglow 0.3 GM3 Tablet SR cautiously, potentially requiring dose modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation with a low dose of Voglow 0.3 GM3 Tablet SR is typical; however, its use is contraindicated in patients with severe liver disease.
What if you forget to take Voglow 0.3 GM3 Tablet SR :
Should you forget a Voglow 0.3 GM3 Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Voglow 0.3 GM3 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |




